Pradaxa (dabigatran etexilate mesylate) is a blood thinning medicine manufactured by Boehringer Ingelheim. It is prescribed to prevent blood clots and stroke in patients with an atrial fibrillation (irregular heartbeat) not caused by a heart valve problem and to treat deep venous thrombosis (blood clot in legs) and pulmonary embolism (blood clot in lungs).
When first approved in 2010, Pradaxa was introduced as a safe and effective alternative to warfarin (also known as Coumadin), a blood-thinning drug that has been on the market since the 1950’s. Consequently, physicians authorized millions of Pradaxa prescriptions. Within months, patients and physicians started reporting serious instances of uncontrollable bleeding. Manageable injuries that would typically be healed by the body itself turned into severe and life-threatening events for those taking Pradaxa. Media reporting giant Bloomberg, reported that by 2014, the drug may have been responsible for more than 1,400 deaths.
Thousands of Pradaxa lawsuits have been filed on behalf of patient victims. If you have taken Pradaxa and have experienced serious side effects act now.